Table 1.
Type | Assay | Strengths | Weaknesses | References |
---|---|---|---|---|
2D | Scratch | Easy to perform Easy to quantify |
Lacks soft substrate for the cells Migration is in 2D |
[12] |
Tube formation | Cells adhere to soft substrate Self-organization into cords Reasonable throughput Tools are available for quantification |
No distinct tip/stalk cell phenotype Basement membrane extracts contain significant levels of growth factors and have a high batch-to-batch variability Limited tube survival (< 2 days) High use of reagents compared to microfluidic assays Lumens not accessible nor perfusable |
[13] | |
3D | Spheroid | Cells grow in 3D in a soft supportive matrix Endothelial cells differentiate into tip and stalk cells Clear lumen formation Fusion of sprouts is observed Laser dissection allows capture of cells Tools available to quantify the angiogenic sprouts |
Lacks spatial control over gradients Higher use of reagents compared to microfluidic assays Spheroids are randomly distributed throughout gel/matrix Lumens are not accessible nor perfusable |
[14, 15, 40] |
Microfluidic | Biochemical gradients can be created and maintained Lumen formation occurs early (more comparable to in vivo) Angiogenic sprouts can be perfused Spatial control over multiple cells (e.g., fibroblasts, pericytes) |
Some devices require for pumps to supply flow and maintain gradients Handling and scalability issues due incompatibility with other equipment Some devices need to be manufactured by the end-user Biocompatibility of the used materials Lack of standardization Limited possibilities to extract a subset of cells |
[18–30, 32, 33] |